Co-lethality studied as an asset against viral drug escape: the HIV protease case.
about
Synthetic lethals in HIV: ways to avoid drug resistance : Running title: Preventing HIV resistance.A New Strategy to Reduce Influenza Escape: Detecting Therapeutic Targets Constituted of Invariance Groups.VIRAPOPS2 supports the influenza virus reassortmentsIdentification of synthetic lethal pairs in biological systems through network information centrality.
P2860
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@ast
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@en
type
label
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@ast
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@en
prefLabel
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@ast
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@en
P2093
P2860
P356
P1433
P1476
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
@en
P2093
Anne Vanet
Emmanuelle Ollivier
Laurent Marsan
Sophie Brouillet
Thomas Valere
P2860
P2888
P356
10.1186/1745-6150-5-40
P577
2010-06-17T00:00:00Z
P5875
P6179
1000044648